When our bodies undergo biological, physical, or chemical injury, the process of inflammation is its normal reaction. Generally, it helps repair or regenearate the damaged cells and tissues. But in some cases, the inflammatory process overshoots and does more harm than good. This is where Lyprinol comes in.
Lyprinol is a stabilized marine extract made from a combination of the highly regarded Omega-3 polyunsaturated fatty acids (PUFAs) and other lipid groups. Because of its impressive anti-inflammatory properties, several researches have been conducted to check its safety and efficacy. Lyprinol has passed these tests with flying colors.
What are some of the instances when excessive inflammatory responses become harmful? A common case is the condition osteoarthritis (also known as degenerative joint disease or degenerative arthritis) wherein low-grade inflammation is coupled with pain in the joints.
It affects the "wear and tear" joints of the hands, feet, knees, shoulders, back, hips, and elbows. Pain is experienced because the cartilage that is supposed to act as a cushion between the joints is worn and the condition is aggravated by several years of hard work and, at times, injury.
When a signal is received to initiate inflammation, one of the biomolecular mechanisms that take place is the conversion of arachidonic acid into inflammation-aiding substances. This process happens via two pathways: the cyclo-oxygenase (COX) pathway which results in the formation of thromboxanes and prostaglandins, and the 5-lipoxygenase (LOX) pathway which forms leukotrienes.
The latter's products (LTB 4, and its metabolites LTC 4, LTD 4, and LTE 4) are potent inflammation supporters. The anti-inflammatory drugs we use today are known to inhibit the cyclo-oxygenase pathway, thus leaving the 5-lipoxygenase pathway products free to actively support the inflammatory process.
When this happens, the LTB 4 metabolites thrive and may possibly give rise to damaging inflammation. They are powerful bronchoconstricting agents and could could even bring the patient into anaphylactic shock.
Because of this, scientists will stop at nothing to find a treatment which effectively inhibits the 5-lipoxygenase pathway. They then discovered Lyprinol, an extract from the New Zealand green-lipped mussels, which effectively and safely impedes the 5-lipoxygenase pathway.
When these harmful leukotrienes are inhibited with the stable Lyprinol, persistent and damaging inflammation is markedly reduced.
When compared with other products of the same nature, Lyprinol can boast of remarkable results:
In a study published in the journal, "Inflammopharmacology," Lyprinol was tested to be 100x more powerful than Max EPA; 125x more effective than green-lipped musel powder; 175x more powerful than salmon oil or evening primrose oil; and 200x more effective than flax oil in the treatment of joint inflammation relative to arthritis.
